Bispecific molecules directed to the Fc receptor for IgA (FcαRI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1677-1686

  Deo, Yashwant M ^a   Sundarapandiyan, Karuna ^a   Keler, Tibor ^a   Wallace, Paul K ^b   Graziano, Robert F ^a  

^a MEDAREX INC   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; TUMOR ANTIGEN;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CROSS LINKING; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, NEOPLASM; BINDING SITES, ANTIBODY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; MICE; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; PLASMACYTOMA; PROTEIN BINDING; RECEPTORS, FC; TUMOR CELLS, CULTURED;

EID: 0032519427     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kerr, M. A. 1990. The structure and function of human IgA. Biochem. J. 271:285.
2. Albrechtsen, M., G. R. Yeaman, and M. A. Kerr. 1988. Characterization of the IgA receptor from human polymorphonuclear leucocytes. Immunology 64:201.
3. Monteiro R., C. H. Kubagawa, and M. D. Cooper. 1990. Cellular distribution, regulation and biochemical nature of an Fcα receptor in humans. J. Exp. Med. 171:597.
4. Morton, H. C., M. van Egmond, and J. G. J. van de Winkel. 1996. Structure and function of human IgA Fc receptors (FcαR). Crit. Rev. Immunol. 16:423.
5. 2+ mobilization in rat and human mesangial cells. J. Immunol. 156:4369.
6. Gessl, A., M. Willheim, A. Spittler, H. Agis, W. Krugluger, and G. Boltz-Nitulescu. 1994. Influence of tumor necrosis factor-α on the expression of FcIgG and IgA receptors, and other markers by cultured human blood monocytes and U937 cells. Scand. J. Immunol. 39:151.
7. Hostoffer, R. W., I. Krukovets, and M. Berger. 1994. Enhancement by tumor necrosis factor-α of Fcα receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 170:82.
8. Shen, L., J. E. Collins, M. H. Schoenborn, and C. R. Maliszewski. 1994. Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J. Immunol. 152:4080.
9. Schiller, C., A. Spittler, M. Willheim, Z. Szepfalusi, H. Agis, M. Koller, M. Peterlik, G. Boltz-Nitulescu. 1994. Influence of suramin on the expression of Fc receptors and other markers on human monocytes and U937 cells, and on their phagocytic properties. Immunology 81:598.
10. Reterink, T. J. F., E. W. N. Levarht, N. Klar-Mohamed, L. A. Van Es, and M. R. Daha. 1996. Transforming growth factor-beta1 (TGF-β1) down regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin. Exp. Immunol. 103:161.
11. Morton, H. C., I. E. van den Herik-Oudijk, P. Vossebeld, A. Snijders, A. J. Verhoeven, P. J. A. Capel, J. G. J. van de Winkel. 1995. Functional association between the human myeloid IgA Fc receptor (CD89) and the FcR γ chain: molecular basis for CD89/FcR γ chain association. J. Biol. Chem. 270:29781.
12. Pfefferkorn, L. C., and Z. Yeaman. 1995. Association of IgA-Fc receptor (FCαR) with Fc∈RI γ2 subunits in U937 cells: aggregation induces tyrosine phosphorylation of γ2. J. Immunol. 153:3228.
13. Saito, K., K. Suzuki, H. Matsuda, and K. Okimura. 1995. Physical association of Fc receptor γ homodimer with IgA receptor. J. Allergy Clin. Immunol. 96:1152.
14. Mazangera, R. L., and M. A. Kerr. 1990. The specificity of the IgA receptor purified from human neutrophils. Biochem. J. 272:159.
15. Patty, C., A. Herbelin, A. Lihuen, J. F. Bach, and R. C. Monteiro. 1995. Fc alpha receptors mediate release of tumor necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation. Immunology 86:1.
16. Stewart, W. W., R. L. Maz-Yegera, L. Shen, and M. A. Kerr. 1994. Unaggregated serum IgA binds to neutrophil Fc alpha R at physiological concentrations and is endocytosed but cross-linking is necessary to elicit a respiratory burst. J. Leukocyte Biol. 56:481.
17. Stewart, W. W., and M. A. Kerr. 1990. The specificity of the human IgA receptor (FcαR) determined by measurement of chemiluminescence induced by serum or secretary IgA1 or IgA2. Immunology 71:328.
18. Shen, L. 1992. A monoclonal antibody specific for immunoglobulin A receptor triggers polymorphonuclear neutrophil superoxide release. J. Leukocyte Biol. 51: 373.
19. Michon, J., S. Moutel, J. Barbet, J. L. Romet-Lemonne, Y. M. Deo, W. H. Fridman, and J. L. Teillaud. 1995. In vitro killing of neuroblastoma cells by neutrophils derived from granulocyte colony-stimulated factor-treated cancer patients using an anti-disialoganglioside/anti-FcγRI (CD64) bispecific antibody. Blood 86:1124.
20. Bakács, T., J. Lee, M. B. Moreno, C. M. Zacharchuk, M. S. Cole, J. Y. Tso, C. H. Paik, J. M. Ward, and D. M. Segal. 1995. A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma. Int. Immunol. 7:947.
21. Graziano, R. F., C. Somasundaram, and J. Goldstein. 1995. The production of bispecific antibodies. In Bispecific Antibodies. M. W. Fanger, ed. R. G. Landes Company, Austin, pp. 1-26.
22. Goldstein, J., R. F. Graziano, K. Sundarapandiyan, C. Somasundaram, and Y. M. Deo. 1997. Cytolytic and cytostatic properties of an anti-human FcγRI (CD64) × epidermal growth factor bispecific fusion protein. J. Immunol. 158: 872.
23. Fanger, M., L. Shen, R. F. Graziano, and P. M. Guyre. 1989. Cytotoxicity mediated by human Fc receptors for IgG. Immunol. Today 10:92.
24. Deo, Y. M., R. F. Graziano, R. Repp, and J. G. J. van de Winkel. 1997. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies. Immunol. Today 18:127.
25. Monteiro, R. C., M. D. Cooper, and H. Kubagawa. 1992. Molecular heterogenicity of Fcα receptor detected by receptor-specific monoclonal antibodies. J. Immunol. 148:1764.
26. Frankel, A. E., D. B. Ring, F. Tringale, and S. T. Hsieh-Ma. 1985. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies. J. Biol. Response Modif. 4:273-286.
27. Kettleborough, C. A., J. Saldanha, V. J. Heath, C. J. Morrison, and M. M. Bendig. 1991. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. Protein Eng. 4:773.
28. 2 antibody containing thioether-linked Fab′ fragments. J. Immunol. 139:2367.
29. Mentzer, S. J., P. M. Guyre, S. J. Borakoff, and D. V. Faller. 1986. Spontaneous aggregation as a mechanism of human monocyte purification. Cell. Immunol. 101:312.
30. Munn, D. H., and N.-K. V. Cheung. 1990. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulated factor. J. Exp. Med. 172:231.
31. Keler, T., R. F. Graziano, A. Mandal, P. K. Wallace, J. Fisher, P. M. Guyre, M. W. Fanger, and Y. M. Deo. 1997. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fcγ receptor type I-expressing effector cells. Cancer Res. 57:4008.
32. Ely, P., P. K. Wallace, A. L. Givan, R. F. Graziano, P. M. Guyre, and M. W. Fanger. 1996. Bispecific-armed, interferon γ-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood 87:3813.
33. van de Winkel, J. G. J., and P. J. A. Capel. 1996. Human IgG Fc Receptors. J. G. J. van de Winkel, and P. J. A. Capel, eds. R. G. Landes Company, Austin, TX.
34. Valerius, T., R. Repp, T. P. M. de Wit, S. Berthold, E. Platzer, J. R. Kalden, M. Gramatzki, and J. G. J. van de Winkel. 1993. Involvement of the high affinity receptor for IgG (FcγRI: CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82:931.
35. Stockmeyer, B., T. Valerius, R. Repp, I. A. F. M. Heijnen, H. J. Bühring, Y. M. Deo, J. R. Kalden, M. Gramatzki, and J. G. J. van de Winkel. 1997. Preclinical studies with FcγR bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res. 57:696.
36. Jain, R. K.,. 1994. Barriers to drug delivery in solid tumors. Sci. Am. 271:58.
37. Valone, F. H., P. A. Kaufman, P. M. Guyre, L. D. Lewis, V. Memoli, Y. M. Deo, R. F. Graziano, J. L. Fisher, L. Meyer, M. Mrozek-Orlowski, K. Wardawell, V. Guyre, T. L. Morely, C. Arrizu, and M. W. Fanger. 1995. Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpress the proto-oncogene HER2/neu. J. Clin. Oncol. 13:2281.
38. Falo, L. D., Jr., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
39. Valerius, T., B. Stockmeyer, A. B. van Spriel, R. F. Graziano, I. E. van den Herik-Oudijk, R. Repp, Y. M. Deo, J. Lund, J. R. Kalden, M. Gramatzki, and J. G. J. van de Winkel. 1997. FcγRI (CD89) as a novel trigger molecule for bispecific antibodies. Blood 90:4485.
40. Repp, R., T. Valerius, A. Sendler, M. Gramatzki, H. Iro, J. R. Kalden, and E. Platzer. 1991. Neutrophils express the high affinity receptor for IgG (Fc-gamma RI; CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:995.
41. Weber, J. S., L. Spears, Y. M. Deo, and J. L. Link. 1996. Phase I study of a HER2/neu bispecific antibody with G-CSF in patients with metastatic breast cancer. Proc. American Society of Clinical Oncology 15:354.